Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis

https://doi.org/10.1016/S0006-291X(05)81073-3Get rights and content

Insulin-like growth factor-binding protein-1 (IGFBP-1) was purified from human midtrimester amniotic fluid using monoclonal anti-IGFBP-1 affinity column. Two peaks were obtained in anion exchange chromatography. Both had the same molecular mass of 30 kDa. In monolayer cultures of fetal skin fibroblasts both forms of IGFBP-1 inhibited binding of [125I]IGF-I onto the cells, but amplified the IGF-I-stimulated [3H]thymidine incorporation into the same cells. Radiolabeled IGFBP-1 did not bind to the cells. No detectable IGFBP-1 was released into conditioned medium from the cells, and they contained no specific IGFBP-1 mRNA. Recently we found that the same IGFBP-1 preparation inhibits IGF-I-stimulated [3H]thymidine incorporation into human hyperstimulated granulosa cells (1). These results show that, depending on target cells, the same protein is capable of either stimulating or inhibiting DNA synthesis.

References (32)

  • PovoaG. et al.

    Biochem. Biophys. Res. Commun.

    (1985)
  • KoistinenR. et al.

    Clin. Chim. Acta

    (1987)
  • JulkunenM. et al.

    FEBS Lett.

    (1988)
  • BrinkmanA. et al.

    Biochem. Biophys. Res. Commun.

    (1988)
  • RoghaniM. et al.

    FEBS Lett.

    (1989)
  • BusbyW.H. et al.

    J. Biol. Chem.

    (1988)
  • MassaguéJ. et al.

    J. Biol. Chem.

    (1982)
  • De MellowJ.S.M. et al.

    Biochem. Biophys. Res. Commun.

    (1988)
  • AngervoM. et al.

    Hum. Reprod.

    (1990)
  • FurlanettoR.W.

    J. Clin. Endocrinol. Metab.

    (1980)
  • Wood, W.I., Cachianes, G., Henzel, W.J., Winslow, G.A., Spencer, S.A., Hellmiss, R., Martin, J.L. and Baxter, R.C. Mol....
  • LeeY-L. et al.

    Mol. Endocrinol.

    (1988)
  • BrinkmanA. et al.

    EMBO J.

    (1988)
  • GrundmanU. et al.

    Nucleic Acids Res.

    (1988)
  • AlitaloT. et al.

    Hum. Genet.

    (1989)
  • CubbageM.L. et al.

    Mol. Endocrinol.

    (1989)
  • Cited by (49)

    • IGFBP-1 hyperphosphorylation in response to leucine deprivation is mediated by the AAR pathway

      2015, Molecular and Cellular Endocrinology
      Citation Excerpt :

      IGFBP-1 functions by binding IGF-I and sequestering it from its receptor, IGF-1R, consequently preventing it from transducing mitogenic signals (Clemmons et al., 1995; Firth and Baxter, 2002; Valentinis and Baserga, 2001). Phosphorylation of IGFBP-1 increases the binding affinity of IGFBP-1 for IGF-I (Jones et al., 1991) and sequesters IGF-I, thereby decreasing IGF-I bioavailability (Firth and Baxter, 2002; Koistinen et al., 1990; Wong et al., 1999; Yu et al., 1998). Human FGR fetuses often have decreased fetal circulating levels of essential amino acids, such as leucine (Regnault et al., 2013; Sathishkumar et al., 2011; Teodoro et al., 2012; Wu, 2009).

    • Normal and Aberrant Growth

      2011, Williams Textbook of Endocrinology, Twelfth Edition
    • IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

      2009, Trends in Endocrinology and Metabolism
      Citation Excerpt :

      Many of the IGFBPs undergo widespread proteolysis, but proteolysis of IGFBP-1 has, so far, only been reported in specific circumstances [33,34]. IGFBP-1 can facilitate transcapillary delivery of IGF-I to tissues [35], and interactions of IGFBP-1 with extracellular matrix or cell surfaces have been postulated to deliver bioactive IGF-I to its receptor [5,36]. Several reports demonstrate that IGFBP-1 can stimulate cellular events in the absence of IGFs, indicating that IGFBP-1 can activate cell-surface receptors directly.

    View all citing articles on Scopus
    View full text